Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
NWFL
|
Meg L Hungerford |
BUY
Grant, award, or other acquisition
|
Indirect | 50 Added 50.0% |
$1,641
$32.81 p/Share
|
Dec 12
2017 |
|
NWFL
|
Ralph A Matergia |
BUY
Grant, award, or other acquisition
|
Indirect | 50 Added 50.0% |
$1,641
$32.81 p/Share
|
Dec 12
2017 |
|
NWFL
|
Kenneth A Phillips |
BUY
Grant, award, or other acquisition
|
Indirect | 50 Added 50.0% |
$1,641
$32.81 p/Share
|
Dec 12
2017 |
|
NWFL
|
William S Lance |
BUY
Grant, award, or other acquisition
|
Indirect | 1,500 Added 50.0% |
$49,215
$32.81 p/Share
|
Dec 12
2017 |
|
NWFL
|
Robert J Mancuso
EVP & COO |
BUY
Grant, award, or other acquisition
|
Indirect | 1,500 Added 50.0% |
$49,215
$32.81 p/Share
|
Dec 12
2017 |
|
AXP
|
Ashwini Gupta
Pres, Crdt Risk/Glbl Info Mgt |
SELL
Open market or private sale
|
Direct | 56,680 Reduced 17.63% |
$5,628,891
$99.31 p/Share
|
Dec 12
2017 |
|
AXP
|
Ashwini Gupta
Pres, Crdt Risk/Glbl Info Mgt |
BUY
Exercise of conversion of derivative security
|
Direct | 89,533 Added 21.78% |
$1,496,096
$16.71 p/Share
|
Dec 12
2017 |
|
NTLA
|
Novartis Institutes For Bio Medical Research, Inc.
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 1,523,000 Reduced 26.94% |
$27,870,899
$18.3 p/Share
|
Dec 12
2017 |
|
PG
|
Kenneth I Chenault
Director |
BUY
Grant, award, or other acquisition
|
Direct | 307 Added 0.88% |
-
|
Dec 12
2017 |
|
PG
|
Terry J Lundgren
Director |
BUY
Grant, award, or other acquisition
|
Direct | 362 Added 2.19% |
-
|
Dec 12
2017 |
|
PG
|
Francis S Blake
Director |
BUY
Grant, award, or other acquisition
|
Direct | 307 Added 3.58% |
-
|
Dec 12
2017 |
|
PG
|
Scott D Cook
Director |
BUY
Grant, award, or other acquisition
|
Direct | 348 Added 0.48% |
-
|
Dec 12
2017 |
|
UNH
|
William C Ballard Jr
Director |
BUY
Grant, award, or other acquisition
|
Direct | 75 Added 0.1% |
-
|
Dec 12
2017 |
|
UNH
|
Richard T Burke
Director |
BUY
Grant, award, or other acquisition
|
Direct | 75 Added 0.0% |
-
|
Dec 12
2017 |
|
UNH
|
Timothy Patrick Flynn
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4 Added 0.34% |
-
|
Dec 12
2017 |
|
UNH
|
Michele J Hooper
Director |
BUY
Grant, award, or other acquisition
|
Direct | 97 Added 0.3% |
-
|
Dec 12
2017 |
|
UNH
|
Rodger A Lawson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 70 Added 0.25% |
-
|
Dec 12
2017 |
|
UNH
|
Rice Valerie Md Montgomery
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1 Added 0.7% |
-
|
Dec 12
2017 |
|
UNH
|
Glenn M Renwick
Director |
BUY
Grant, award, or other acquisition
|
Direct | 142 Added 0.32% |
-
|
Dec 12
2017 |
|
UNH
|
Kenneth Irwin Shine
Director |
BUY
Grant, award, or other acquisition
|
Direct | 97 Added 0.34% |
-
|
Dec 12
2017 |
|
UNH
|
Gail R Wilensky |
BUY
Grant, award, or other acquisition
|
Direct | 70 Added 0.12% |
-
|
Dec 12
2017 |
|
UNH
|
Andrew Witty
CEO, UHG |
BUY
Grant, award, or other acquisition
|
Direct | 1 Added 0.7% |
-
|
Dec 12
2017 |
|
UNH
|
Stephen J Hemsley
CEO, UHG |
BUY
Grant, award, or other acquisition
|
Direct | 447 Added 0.03% |
-
|
Dec 12
2017 |
|
UNH
|
Steven H Nelson
EVP & CEO, UnitedHealthcare |
BUY
Grant, award, or other acquisition
|
Direct | 65 Added 0.33% |
-
|
Dec 12
2017 |
|
UNH
|
Larry C Renfro
Vice Chmn, UHG and CEO, Optum |
BUY
Grant, award, or other acquisition
|
Direct | 122 Added 0.06% |
-
|
Dec 12
2017 |
|
UNH
|
Thomas E Roos
Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct | 63 Added 0.28% |
-
|
Dec 12
2017 |
|
UNH
|
Marianne D Short
EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct | 59 Added 0.07% |
-
|
Dec 12
2017 |
|
UNH
|
David S Wichmann
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 134 Added 0.02% |
-
|
Dec 12
2017 |
|
UNH
|
D Ellen Wilson
Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct | 52 Added 0.16% |
-
|
Dec 12
2017 |
|
UNH
|
John F Rex
President & CFO |
BUY
Grant, award, or other acquisition
|
Direct | 86 Added 0.14% |
-
|
Dec 12
2017 |
|
LGF-B
|
John C Malone
Director |
SELL
Open market or private sale
|
Indirect | 26,230 Reduced 1.38% |
$774,310
$29.52 p/Share
|
Dec 12
2017 |
|
PLNT
|
Dorvin D Lively
President |
SELL
Open market or private sale
|
Direct | 67,273 Reduced 100.0% |
$2,104,299
$31.28 p/Share
|
Dec 12
2017 |
|
PLNT
|
Dorvin D Lively
President |
BUY
Conversion of derivative security
|
Direct | 67,273 Added 50.0% |
-
|
Dec 12
2017 |
|
CFG
|
Brad L. Conner
Vice Chair, Consumer Banking |
SELL
Bona fide gift
|
Direct | 743 Reduced 0.57% |
-
|
Dec 12
2017 |
|
SDOI
|
Standard General L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 120 Added 0.0% |
$1,285
$10.71 p/Share
|
Dec 12
2017 |
|
SDOI
|
Standard General L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 18,720 Added 0.26% |
$187,574
$10.02 p/Share
|
Dec 12
2017 |
|
CHN
|
City Of London Investment Group PLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 2,374 Added 2.12% |
$50,637
$21.33 p/Share
|
Dec 12
2017 |
|
IIF
|
City Of London Investment Group PLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 6,800 Reduced 0.42% |
$241,604
$35.53 p/Share
|
Dec 12
2017 |
|
TTF
|
City Of London Investment Group PLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 5,351 Reduced 34.49% |
$58,807
$10.99 p/Share
|
Dec 12
2017 |
|
NTRS
|
Frederick H Waddell
Chairman |
SELL
Bona fide gift
|
Indirect | 1,345 Reduced 1.87% |
-
|
Dec 12
2017 |
|
NIC
|
Michael Joseph Vogel
SVP Comm Bank-Nicolet Nat Bank |
SELL
Bona fide gift
|
Direct | 115 Reduced 0.97% |
-
|
Dec 12
2017 |
|
ACGL
|
Constantine Iordanou
Chairman |
SELL
Bona fide gift
|
Direct | 1,775 Reduced 1.63% |
-
|
Dec 12
2017 |
|
USB
|
Gunjan Kedia
President |
SELL
Payment of exercise price or tax liability
|
Direct | 2,298 Reduced 8.47% |
$127,010
$55.27 p/Share
|
Dec 12
2017 |
|
SMMF
|
Dewey F Bensenhaver
Director |
SELL
Open market or private sale
|
Direct | 946 Reduced 1.75% |
$24,937
$26.36 p/Share
|
Dec 12
2017 |
|
NEE
|
James L Robo
Director |
BUY
Bona fide gift
|
Indirect | 34,600 Added 47.69% |
-
|
Dec 12
2017 |
|
NEE
|
James L Robo
Director |
SELL
Bona fide gift
|
Direct | 34,600 Reduced 12.79% |
-
|
Dec 12
2017 |
|
BMY
|
Thomas J. Lynch Jr.
EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 5,300 Reduced 36.43% |
$335,172
$63.24 p/Share
|
Dec 12
2017 |
|
PG
|
Angela F Braly
Director |
BUY
Grant, award, or other acquisition
|
Direct | 348 Added 1.08% |
-
|
Dec 12
2017 |
|
PG
|
W James Mcnerney Jr
Director |
BUY
Grant, award, or other acquisition
|
Direct | 390 Added 0.56% |
-
|
Dec 12
2017 |
|
XOM
|
Bryan W Milton
Vice President |
SELL
Open market or private sale
|
Direct | 7,281 Reduced 3.62% |
$606,070
$83.24 p/Share
|
Dec 12
2017 |